| ID | Sequence | Length | GC content |
|---|---|---|---|
| MAPT-AS1:1 | ACACGCCGGGCGCCCUGCGCUCCGAGCGCUGAGAAAGAAAUCCGCCCCG… | 3602 nt | 0.5694 |
| MAPT-AS1:2 | GAGAAAGAAAUCCGCCCCGAGAUGCACCUGCAGCCCCGCGCCCAUCCGU… | 632 nt | 0.5348 |
| MAPT-AS1:3 | GCGGCCGCCGAGUCCGUCCACAUCGCCAGGCCAGGUGAACCCUGCCUUU… | 1190 nt | 0.6134 |
| MAPT-AS1:4 | GCGGCCGCCGAGUCCGUCCACAUCGCCAGGCCAGGAGUCAGAACAAGGA… | 840 nt | 0.5131 |
| MAPT-AS1:5 | AAAGCUGUGUGGUCCCCAGCCGAGGGCGCUGCUGUGGGGCACAGGGUCC… | 432 nt | 0.5139 |
| MAPT-AS1:6 | CGAGGGCGCUGCUGUGGGGCACAGGGUCCCUCUAGAAUGAUGCCCCCCA… | 295 nt | 0.5492 |
| MAPT-AS1:7 | ACACGCCGGGCGCCCUGCGCUCCGAGCGCUGAGAAAGAAAUCCGCCCCG… | 662 nt | 0.5468 |
| MAPT-AS1:8 | ACACGCCGGGCGCCCUGCGCUCCGAGCGCUGAGAAAGAAAUCCGCCCCG… | 1307 nt | 0.6236 |
Involved in regulatory ncRNA-mediated gene silencing. Implicated in Parkinson's disease. [provided by Alliance of Genome Resources, Jul 2025]
A review of the literature indicates that the MAPT-AS1 is detected in the cerebellum of Parkinson's disease patients [Das et al. DOI:10.1080/21655979.2021.2003667].